E. Wilkerson-Bnnsko
FDA investigator
Appears on 1 document from 2003, mostly at sites in California. Most often cites what records must accompany an HCT/P after the donor-eligibility determination is complete; and what records must I retain? (21 CFR 1271.55).
- 1
- Documents on file
- 1.0
- Observations per 483
- 2003
- First seen
- 2003
- Most recent
What they cite most
From 1 observations- 21 CFR 1271.55What records must accompany an HCT/P after the donor-eligibility determination is complete; and what records must I retain?1
Activity by year
2003: 1
Where
California 1
Is E. Wilkerson-Bnnsko coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2003-08-14 | 483 Nuvasive, Inc.Aug 14, 2003 · San Diego, California | San Diego, California | 1 |
About this profile
What does E. Wilkerson-Bnnsko inspect?
E. Wilkerson-Bnnsko appears on 1 document on file covering 1 site, mostly in California.
What do they cite most often?
21 CFR 1271.55 (what records must accompany an HCT/P after the donor-eligibility determination is complete; and what records must I retain?).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for E. Wilkerson-Bnnsko is dated Aug 14, 2003.